FDA's new-drug approvals to reach at least 21 this year

12/21/2008 | Houston Chronicle (tiered subscription model)

The FDA is poised to clear at least 21 new medicines this year, increasing from 18 in 2007, despite the agency's failure to meet review deadlines for at least 15 treatments. Industry executives cited tougher approval standards as one reason for the delays. John Jenkins, director of the FDA's Office of New Drugs, said the agency evaluates "each application on its merits."

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA